A perspective on re-evaluating digoxin's role in the current management of patients with chronic systolic heart failure: targeting serum concentration to reduce hospitalization and improve safety profile-Reference-Cited by-同舟云学术

A perspective on re-evaluating digoxin's role in the current management of patients with chronic systolic heart failure: targeting serum concentration to reduce hospitalization and improve safety profile

Published:2014-02-23 Issue:5 Volume:16 Page:483-493
ISSN:1388-9842
Container-title:European Journal of Heart Failure
language:en
Short-container-title:Eur J Heart Fail

Author:

Adams Kirkwood F.¹,Ghali Jalal K.²,Herbert Patterson J.³,Stough Wendy Gattis⁴,Butler Javed⁵,Bauman Jerry L.⁶,Ventura Hector O.⁷,Sabbah Hani⁸,Mackowiak John I.⁹,van Veldhuisen Dirk J.¹⁰

Affiliation:

1. Departments of Medicine and Radiology, School of Medicine, Division of Cardiology; University of North Carolina at Chapel Hill; Chapel Hill NC USA

2. Division of Cardiology; Mercer University School of Medicine; Macon GA USA

3. Division of Pharmacotherapy and Experimental Therapeutics; University of North Carolina at Chapel Hill Eshelman School of Pharmacy; Chapel Hill NC USA

4. Department of Clinical Research; Campbell University College of Pharmacy and Health Sciences; Buies Creek NC USA

5. Department of Medicine, Division of Cardiology; Emory University; Atlanta GA USA

6. Departments of Pharmacy Practice and Medicine, Section of Cardiology, Colleges of Pharmacy and Medicine; University of Illinois at Chicago; Chicago IL USA

7. John Ochsner Heart and Vascular Institute, Ochsner Clinical School; The University of Queensland School of Medicine; New Orleans LA USA

8. Division of Cardiology; Wayne State University, Henry Ford Health System; Detroit MI USA

9. Center for Outcomes Research; Nashville TN USA

10. Department of Cardiology; University of Groningen, University Medical Center Groningen; Groningen the Netherlands

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Reference76 articles.

1. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure;The SOLVD Investigators;N Engl J Med,1991

2. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS);The CONSENSUS Trial Study Group;N Engl J Med,1987

3. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure;Cohn;N Engl J Med,1991

4. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions;The SOLVD Investigators;N Engl J Med,1992

5. The effect of digoxin on mortality and morbidity in patients with heart failure;The Digitalis Investigation Group;N Engl J Med,1997

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Comprehensive Review on Unveiling the Journey of Digoxin: Past, Present, and Future Perspectives;Cureus;2024-03-23

2. A short review on CRP synthesis inhibition in cardiovascular disease;Frontiers in Drug Discovery;2024-03-04

3. NHC/ SHA 2023 Focused update of the 2019 guidelines for the management of heart failure;Journal of the Saudi Heart Association;2023-05-29

4. Whither digitalis? What we can still learn from cardiotonic steroids about heart failure and hypertension;American Journal of Physiology-Heart and Circulatory Physiology;2022-12-01

5. Procyanidin C1 from Viola odorata L. inhibits Na+,K+-ATPase;Scientific Reports;2022-04-29